Label: LORATADINE tablet, orally disintegrating

  • NDC Code(s): 72888-029-09, 72888-029-11
  • Packager: Advagen Pharma Limited
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 25, 2020

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT

    Drug Facts
    Active ingredient (in each tablet)                                                                  Purpose
    Loratadine USP, 10 mg………………………………….....................Antihistamine
    Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: ■ runny nose ■ itchy, watery eyes ■ sneezing ■ itching of the nose or throat
    Warnings
    Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
    Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
    When using a product do not take more than directed. Taking more than directed may cause drowsiness.
    Stop use and ask a doctor if an allergic reaction to this product occurs.
    Seek medical help right away.
    If pregnant or breast-feeding, ask a health professional before use.
    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
    Directions
    • place 1 tablet on tongue; tablet disintegrates, with or without water
    adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours
    Children under 6 years of age ask a doctor
    Consumers with liver or kidney disease ask a doctor
    Other information
    • Phenylketonurics: contains phenylalanine (a component of aspartame) 1.52 mg per 10 mg orally disintegrating tablet.
    • safety sealed: do not use if the individual blister unit imprinted with Loratadine Orally Disintegrating Tablets USP 10 mg is open or torn
    • store between 20° to 25°C (68° to 77°F)
    • use tablet immediately after opening individual blister
    • FDA approved acceptance criteria for assay and organic impurities differs from USP test
    Inactive ingredients
    aspartame, colloidal silicon dioxide, crospovidone, magnesium stearate, maize starch, mannitol, microcrystalline cellulose, peppermint flavor, sodium stearyl fumarate
    Questions or comments?
    Advagen - 888-413-0949
    Distributed by:
    Advagen Pharma Ltd
    666 Plainsboro Road
    Suite 605
    Plainsboro, NJ 08536, USA.

    Manufactured by:
    Rubicon Research Private Limited
    Ambernath, Dist: Thane, 421506 India.
  • PURPOSE

  • INDICATIONS & USAGE

  • WARNINGS

  • DOSAGE & ADMINISTRATION

  • SPL UNCLASSIFIED SECTION

  • INACTIVE INGREDIENT

  • QUESTIONS

  • SPL UNCLASSIFIED SECTION

    Note: Imprint Code - Λ indicated as UpArrowhead in Drug Listing Data Element (DLDE) section.

  • PRINCIPAL DISPLAY PANEL

    Loratadine Orally Disintegrating Tablets USP 10 mg - 10 Tablets - NDC 72888-029-09

    loratadine-odt-usp-10mg-10count

    Loratadine Orally Disintegrating Tablets USP 10 mg - 30 Tablets - NDC 72888-029-11

    loratadine-odt-usp-10mg-30count

  • INGREDIENTS AND APPEARANCE
    LORATADINE 
    loratadine tablet, orally disintegrating
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72888-029
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    ASPARTAME (UNII: Z0H242BBR1)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSPOVIDONE (UNII: 2S7830E561)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    MANNITOL (UNII: 3OWL53L36A)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SODIUM STEARYL FUMARATE (UNII: 7CV7WJK4UI)  
    Product Characteristics
    Colorwhite (White to Off-White) Scoreno score
    ShapeROUNDSize10mm
    FlavorPEPPERMINTImprint Code UpArrowhead43
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72888-029-091 in 1 CARTON09/10/2020
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:72888-029-113 in 1 CARTON09/10/2020
    210 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21428009/10/2020
    Labeler - Advagen Pharma Limited (051627256)
    Registrant - Rubicon Research Private Limited (918629544)
    Establishment
    NameAddressID/FEIBusiness Operations
    Rubicon Research Private Limited677604197manufacture(72888-029) , analysis(72888-029) , pack(72888-029)